MicroRNAs (miRNAs) are tiny fragments of RNA that regulate how genes are expressed in cells. Though only about 20 nucleotides long, they play a powerful role in controlling cellular activity — including processes linked to cancer development.
Changes in miRNA levels often appear before symptoms or imaging findings
Unlike many molecules, miRNAs are stable and detectable in the bloodstream, making them ideal for blood-based analysis
Research shows that multiple solid tumours share miRNA “signatures” that can serve as early warning signals of disease
This makes miRNAs a valuable tool for real-time cancer risk assessment.
The miRoncol Real-time Multi-Cancer Early Risk Assessment measures the expression of hundreds of circulating miRNAs and applies advanced AI to identify patterns linked to cancer biology.
Understanding miRNAs is the first step in appreciating how they can transform cancer prevention.
By tapping into these molecular signals, the miRoncol test offers a new way to see what’s happening in your body today.